FR2355833B1 - - Google Patents

Info

Publication number
FR2355833B1
FR2355833B1 FR7718973A FR7718973A FR2355833B1 FR 2355833 B1 FR2355833 B1 FR 2355833B1 FR 7718973 A FR7718973 A FR 7718973A FR 7718973 A FR7718973 A FR 7718973A FR 2355833 B1 FR2355833 B1 FR 2355833B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7718973A
Other languages
French (fr)
Other versions
FR2355833A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of FR2355833A1 publication Critical patent/FR2355833A1/fr
Application granted granted Critical
Publication of FR2355833B1 publication Critical patent/FR2355833B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FR7718973A 1976-06-23 1977-06-21 Nouveaux 1-(azacyclo-aralcoxyphenyl)-2- ou -3-(bis-arylalcoyl-amino)-alcanes, leur preparation et leur application en tant que medicaments Granted FR2355833A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/699,017 US4091103A (en) 1976-06-23 1976-06-23 Quinolyl or isoquinolyl-lower-alkoxy-phenylene-amino derivatives

Publications (2)

Publication Number Publication Date
FR2355833A1 FR2355833A1 (fr) 1978-01-20
FR2355833B1 true FR2355833B1 (US08063081-20111122-C00044.png) 1980-06-13

Family

ID=24807584

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7718973A Granted FR2355833A1 (fr) 1976-06-23 1977-06-21 Nouveaux 1-(azacyclo-aralcoxyphenyl)-2- ou -3-(bis-arylalcoyl-amino)-alcanes, leur preparation et leur application en tant que medicaments

Country Status (25)

Country Link
US (2) US4091103A (US08063081-20111122-C00044.png)
JP (1) JPS52156871A (US08063081-20111122-C00044.png)
AT (1) AT355575B (US08063081-20111122-C00044.png)
AU (1) AU513828B2 (US08063081-20111122-C00044.png)
BE (1) BE855975A (US08063081-20111122-C00044.png)
CA (1) CA1085404A (US08063081-20111122-C00044.png)
CY (1) CY1167A (US08063081-20111122-C00044.png)
DE (1) DE2727387A1 (US08063081-20111122-C00044.png)
DK (1) DK276877A (US08063081-20111122-C00044.png)
ES (1) ES459963A1 (US08063081-20111122-C00044.png)
FI (1) FI771960A (US08063081-20111122-C00044.png)
FR (1) FR2355833A1 (US08063081-20111122-C00044.png)
GB (1) GB1561516A (US08063081-20111122-C00044.png)
GR (1) GR82332B (US08063081-20111122-C00044.png)
HU (1) HU176501B (US08063081-20111122-C00044.png)
IE (1) IE45151B1 (US08063081-20111122-C00044.png)
IL (1) IL52359A (US08063081-20111122-C00044.png)
KE (1) KE3247A (US08063081-20111122-C00044.png)
MY (1) MY8400031A (US08063081-20111122-C00044.png)
NL (1) NL7706780A (US08063081-20111122-C00044.png)
NO (1) NO148554B (US08063081-20111122-C00044.png)
NZ (1) NZ184457A (US08063081-20111122-C00044.png)
PT (1) PT66689B (US08063081-20111122-C00044.png)
SE (1) SE7707245A0 (US08063081-20111122-C00044.png)
ZA (2) ZA771962B (US08063081-20111122-C00044.png)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7487986B2 (en) * 2002-10-16 2009-02-10 89908, Inc. Retractable vehicle step
US9212127B2 (en) 2004-08-20 2015-12-15 University Of Virginia Patent Foundation T type calcium channel inhibitors
US9427429B2 (en) 2010-03-01 2016-08-30 Tau Therapeutics Llc Cancer diagnosis and imaging

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3906110A (en) * 1973-02-07 1975-09-16 Ciba Geigy Corp Antihypertensive {60 -(1-aralkylaminoalkyl)-aralkoxybenzyl alcohols

Also Published As

Publication number Publication date
FI771960A (US08063081-20111122-C00044.png) 1977-12-24
MY8400031A (en) 1984-12-31
CA1085404A (en) 1980-09-09
GB1561516A (en) 1980-02-20
SE7707245A0 (sv) 1977-12-25
GR82332B (US08063081-20111122-C00044.png) 1984-12-13
ATA439577A (de) 1979-08-15
CY1167A (en) 1983-06-10
KE3247A (en) 1983-01-28
IE45151L (en) 1977-12-23
ZA773744B (en) 1978-05-30
AU513828B2 (en) 1981-01-08
US4091103A (en) 1978-05-23
IL52359A0 (en) 1977-08-31
AU2632777A (en) 1979-01-04
DE2727387A1 (de) 1977-12-29
IL52359A (en) 1980-03-31
NL7706780A (nl) 1977-12-28
AT355575B (de) 1980-03-10
PT66689B (en) 1978-11-17
NZ184457A (en) 1980-03-05
IE45151B1 (en) 1982-06-30
NO148554B (no) 1983-07-25
NO772211L (no) 1977-12-27
BE855975A (fr) 1977-12-22
ES459963A1 (es) 1978-05-01
HU176501B (en) 1981-03-28
DK276877A (da) 1977-12-24
FR2355833A1 (fr) 1978-01-20
US4110457A (en) 1978-08-29
PT66689A (en) 1977-07-01
ZA771962B (en) 1978-03-29
JPS52156871A (en) 1977-12-27

Similar Documents

Publication Publication Date Title
FR2375519B2 (US08063081-20111122-C00044.png)
JPS5336734U (US08063081-20111122-C00044.png)
FR2362207B1 (US08063081-20111122-C00044.png)
JPS52125780U (US08063081-20111122-C00044.png)
JPS5225902U (US08063081-20111122-C00044.png)
JPS551274Y2 (US08063081-20111122-C00044.png)
FR2368260B1 (US08063081-20111122-C00044.png)
JPS52130081U (US08063081-20111122-C00044.png)
JPS5315644U (US08063081-20111122-C00044.png)
JPS52124006U (US08063081-20111122-C00044.png)
JPS52134497U (US08063081-20111122-C00044.png)
JPS52149349U (US08063081-20111122-C00044.png)
JPS5388431U (US08063081-20111122-C00044.png)
JPS5385856U (US08063081-20111122-C00044.png)
JPS5378353U (US08063081-20111122-C00044.png)
JPS5340365U (US08063081-20111122-C00044.png)
JPS52170360U (US08063081-20111122-C00044.png)
JPS5331993U (US08063081-20111122-C00044.png)
CH598474A5 (US08063081-20111122-C00044.png)
DD126852A1 (US08063081-20111122-C00044.png)
CH595749A5 (US08063081-20111122-C00044.png)
CH596413A5 (US08063081-20111122-C00044.png)
LU75926A1 (US08063081-20111122-C00044.png)
DD126779A1 (US08063081-20111122-C00044.png)
BG27065A3 (US08063081-20111122-C00044.png)

Legal Events

Date Code Title Description
ST Notification of lapse